Clinical trials and research pioneering breakthrough treatments and shaping the future of oncology care.
As we celebrate Clinical Trials Week, we honor the remarkable journey of discovery and innovation that clinical trials represent in the realm of cancer research. At Virginia Cancer Specialists, we stand as a beacon of hope, leading the charge in pioneering breakthrough treatments and shaping the future of oncology care.
Virginia Cancer Specialists isn’t just an ordinary oncology practice; it’s a powerhouse of expertise and compassion. Our multidisciplinary approach, encompassing medical, surgical, and radiation oncology, empowers us to deliver cutting-edge, world-class patient care right in our community. At the heart of our mission lies the Virginia Cancer Specialists Research Institute, with an unwavering commitment to advancing cancer treatment through research and innovation.
Clinical trials are the cornerstone of progress in cancer research, offering a pathway to explore novel therapies and revolutionize patient care. At Virginia Cancer Specialists, we boast a robust clinical trials program. Delving into gene-targeted therapy and immunotherapy across a spectrum of solid tumors and malignant hematology.
“As the co-director of the research institute at Virginia Cancer Specialists, I am proud to lead a team that is at the forefront of cancer research. With the largest Phase 1 program in the region, we are not only advancing science but also ushering in transformative discoveries that hold the promise of better outcomes for our patients,” shares Alexander I Spira MD, PhD, FACP, FASCO. “Every day, we strive to turn hope into reality, shaping a future where cancer is no longer a formidable foe but a conquerable challenge.”
For those considering participation, understanding the clinical trial process is crucial. Clinical trials are research studies conducted with patient volunteers to assess the efficacy and safety of novel therapies. Each trial has specific eligibility criteria, meticulously evaluated by our research team to ensure patient suitability. Patients interested in participating undergo a screening period and, upon meeting criteria, enroll in the trial and initiate treatment.
Participation in clinical trials offers numerous benefits:
Importantly, participants retain the right to withdraw from the trial at any time without impacting their future medical care.
At Virginia Cancer Specialists, we prioritize accessibility and affordability for our patients. Before enrollment, detailed discussions about trial costs are facilitated by our professional billing specialist.
Our research team, comprised of highly experienced and dedicated staff members, manages a diverse portfolio of trials, including Phase I studies, spanning various diseases such as lung cancer, breast cancer, lymphoma, and leukemia.
Since 1999, nearly 80,000 participants have enrolled in more than 1,600 clinical trials through US Oncology Research. As we commemorate Clinical Trials Week, we extend an open invitation to all those seeking hope, innovation, and transformation. Together, let’s unlock the power of clinical trials and shape a future where cancer is no longer a devastating diagnosis, but a conquerable challenge.
